New Guidelines: Managing Blood Thinners Before Surgery

Published: Sep 23, 2024

Recent medical guidelines have updated how doctors should manage blood thinners in patients undergoing surgery. These changes aim to reduce complications and simplify care. What do you need to know?

Shift Away from Bridging

One major change is moving away from routine use of 'bridging' therapy. This involves using injectable blood thinners when stopping oral medications before surgery. New evidence shows bridging increases bleeding risk without reducing clots for most patients. It's now reserved for only the highest-risk cases.

Tailored Approach for Each Patient

Guidelines now emphasize a more personalized approach. Doctors should consider each patient's specific clotting risk, bleeding risk, and type of blood thinner. For example, patients with atrial fibrillation have different needs than those with mechanical heart valves. This individualized strategy helps balance risks more effectively.

Recent guidelines update how blood thinners should be managed in patients undergoing surgery, emphasizing a tailored approach and reducing the use of bridging therapy.

Timing of Medication Stops and Starts

New recommendations provide clearer guidance on when to stop and restart blood thinners around surgery. Newer medications like apixaban or rivaroxaban can often be stopped closer to surgery than warfarin. After surgery, most patients can restart their medication within 24-72 hours, depending on bleeding risk.

Frequently Asked Questions

Yes, but specific recommendations vary by medication type.

Possibly - discuss with your doctor if you have upcoming procedures.

They're widely accepted but some regional variations exist.

Major updates typically occur every 3-5 years as new evidence emerges.

Key Takeaways

These updated guidelines aim to improve safety and simplify management of blood thinners before surgery.

Consult with Doctronic to ensure your perioperative anticoagulation plan aligns with the latest guidelines.

Related Articles

References

Douketis JD et al. Chest. 2022;162(5):e207-e253.

Steffel J et al. Europace. 2021;23(10):1612-1676.

Always discuss health information with your healthcare provider.